×
Volver a Agenda
IMEDS: A Collaboration Based on the FDA's Sentinel Initiative
Session Chair(s)
June Wasser, MA
Executive Director, Reagan-Udall Foundation For the FDA, United States
This forum will educate industry on how, when, and why, utilizing IMEDS may be helpful to answering drug safety and other types of pharmacovigilance research questions.
Learning Objective : Explain the IMEDS program and the role of the Reagan-Udall Foundation for the FDA; Distinguish the IMEDS database from other safety study databases; Illustrate the purpose and uses of the IMEDS program.
Speaker(s)
Cheryl Walraven, PHD
Director, Informatics, Aetna, United States
Panelist
Jeffrey Brown, PHD, MA
Associate Professor, Department of Population Medicine, Harvard Pilgrim Health Care Institute/Harvard Medical School, United States
IMEDS Analytic Center: Supporting the IMEDS Research Portfolio
Claudia Salinas, PHD
Senior Director, GPS Pharmacoepidemiology, Eli Lilly and Company, United States
Panelist
¿Tiene una cuenta?